Intersect Ent Inc (XENT) Gross Profit Margin starting from the first quarter 2022 to first quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Intersect Ent Inc   (NASDAQ: XENT)


Intersect Ent Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XENT Gross Profit Margin (Mar 31 2022)
Q1 		(Dec 31 2021)
Q4 		(Sep 30 2021)
Q3 		(Jun 30 2021)
Q2 		(Mar 31 2021)
Q1
Y / Y Revenue Change -11.32 %
Seq. Revenue Change -29.66 %
Revenue In Millions $21.58
Gross Profit Margin 64.36 %
Gross Profit Margin Total Ranking # 1247
Gross Profit In Millions $13.89
Y / Y Gross Profit Change -12.52 %
Seq. Gross Profit Change -38.38 %


Commenting First Quarter 2022 Gross Profit Margin
Intersect Ent Inc experienced contraction in Gross Profit by -38.38 % to $22 millions and Revenue by -29.66 %, while Gross Profit Margin fell to 64.36 %, below company*s average Gross Profit Margin.


Observing first quarter 2022 results within Medical Equipment & Supplies industry 83 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 840 to 1247.
Learn about Gross Margin
XENT's Gross Profit Margin first quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 256
Overall # 1225

Gross Profit Margin Statistics
High Average Low
85.91 % 75.87 % 24.78 %
(Mar 31 2017)   (Jun 30 2020)


XENT Gross Income Trends • More of XENT's Profitabilty Ratios • XENT Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
XENT's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
XENT's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for XENT's Competitors
Gross Profit Margin Profit Margin for Intersect Ent Inc 's Suppliers
Gross Profit Margin Profit Margin for XENT's Customers

You may also want to know
XENT's Annual Growth Rates XENT's Profitability Ratios XENT's Asset Turnover Ratio XENT's Dividend Growth
XENT's Roe XENT's Valuation Ratios XENT's Financial Strength Ratios XENT's Gross Profit Growth
XENT's Roa XENT's Inventory Turnover Ratio XENT's Growth Rates XENT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2022, within Medical Equipment & Supplies Industry Gross Profit MarginMar 31 2022 MRQ Gross ProfitMar 31 2022 MRQ Revenue
Arch Therapeutics Inc   98.26 %$ 0.986  Millions$ 1.003  Millions
Docgo Inc   98.13 %$ 115.691  Millions$ 117.892  Millions
Semler Scientific inc   93.08 %$ 13.046  Millions$ 14.016  Millions
Delcath Systems Inc   91.27 %$ 0.345  Millions$ 0.378  Millions
Sanara Medtech Inc   89.69 %$ 7.006  Millions$ 7.811  Millions
Vycor Medical Inc   89.35 %$ 0.280  Millions$ 0.314  Millions
Inari Medical Inc   88.51 %$ 76.785  Millions$ 86.752  Millions
Si bone inc   86.71 %$ 19.456  Millions$ 22.439  Millions
Fonar Corporation  86.55 %$ 21.265  Millions$ 24.571  Millions
Shockwave Medical Inc   86.23 %$ 80.741  Millions$ 93.631  Millions
Nexalin Technology Inc   85.77 %$ 0.277  Millions$ 0.323  Millions
Inspire Medical Systems inc   85.58 %$ 59.378  Millions$ 69.382  Millions
Co diagnostics Inc   85.54 %$ 19.417  Millions$ 22.699  Millions
Paragon 28 inc   83.59 %$ 34.580  Millions$ 41.371  Millions
Mimedx Group Inc   83.13 %$ 48.958  Millions$ 58.894  Millions
Axogen inc   82.11 %$ 25.461  Millions$ 31.007  Millions
Agape Atp Corporation  82.03 %$ 0.336  Millions$ 0.409  Millions
Therapeutic Solutions International Inc   81.23 %$ 0.069  Millions$ 0.085  Millions
Treace Medical Concepts Inc   81.04 %$ 23.541  Millions$ 29.047  Millions
Electrocore Inc   81.04 %$ 1.539  Millions$ 1.899  Millions
Abiomed Inc   80.93 %$ 218.393  Millions$ 269.850  Millions
Surmodics Inc   80.44 %$ 20.999  Millions$ 26.106  Millions
Guided Therapeutics Inc   80.00 %$ 0.004  Millions$ 0.005  Millions
Novocure Limited  79.84 %$ 109.820  Millions$ 137.547  Millions
Sight Sciences Inc   79.62 %$ 11.848  Millions$ 14.881  Millions
Orthopediatrics Corp  79.28 %$ 18.566  Millions$ 23.417  Millions
Staar Surgical Co  77.95 %$ 49.264  Millions$ 63.200  Millions
Neurometrix Inc   77.90 %$ 1.794  Millions$ 2.302  Millions
Zynex inc   77.73 %$ 24.162  Millions$ 31.083  Millions
Edwards Lifesciences Corporation  77.68 %$ 1,041.900  Millions$ 1,341.200  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.